Growth • Zynex
ZYXI
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
33,4%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
-11,6%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
-20,6%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
-18,8%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
-17,6%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
15,1%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!